Limitations in the effect of screening on breast cancer mortality

Journal of Clinical Oncology

Volumn 36, Issue 30, 2018, Pages 2988-2994

  Beau, Anna Belle ^a   Andersen, Per Kragh ^a   Vejborg, Ilse ^b   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BREAST TUMOR; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 85055089198     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2018.78.0270     Document Type: Article

References (25)

1. Nyström L, Rutqvist LE, Wall S, et al: Breast cancer screening with mammography: Overview of Swedish randomised trials. Lancet 341:973-978, 1993.
2. Marmot MG, Altman DG, Cameron DA, et al: The benefits and harms of breast cancer screening: An independent review. Br J Cancer 108:2205-2240, 2013.
3. Lauby-Secretan B, Scoccianti C, Loomis D, et al: Breast-cancer screening-viewpoint of the IARC Working Group. N Engl J Med 372:2353-2358, 2015.
4. Nelson HD, Cantor A, Humphrey L, et al. Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality, 2016.
5. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792, 2005.
6. Welch HG, Prorok PC, O'Malley AJ, et al: Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375:1438-1447, 2016.
7. Autier P, Boniol M, Koechlin A, et al: Effectiveness of and overdiagnosis from mammography screening in the Netherlands: Population based study. BMJ 359:j5224, 2017.
8. Schmidt M, Pedersen L, Sørensen HT: The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 29: 541-549, 2014.
9. Gjerstorff ML: The Danish Cancer Registry. Scand J Public Health 39:42-45, 2011 (7 Suppl).
10. Helweg-Larsen K: The Danish Register of Causes of Death. Scand J Public Health 39:26-29, 2011 (7 Suppl).
11. Olsen AH, Njor SH, Vejborg I, et al: A model for determining the effect of mammography service screening. Acta Oncol 44: 120-128, 2005.
12. Wikipedia, the free encyclopedia: Difference in differences. https://en.wikipedia.org/wiki/Difference-in-differences.
13. Nyström L, Andersson I, Bjurstam N, et al: Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 359:909-919, 2002.
14. Shapiro S: Evidence on screening for breast cancer from a randomized trial. Cancer 39: 2772-2782, 1977 (6, Suppl).
15. Baker SG, Kramer BS, Prorok PC: Early reporting for cancer screening trials. J Med Screen 15: 122-129, 2008.
16. Duffy SW, Tabar L, Chen H-H, et al: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95: 458-469, 2002.
17. Nyström L, Bjurstam N, Jonsson H, et al: Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. J Med Screen 24:34-42, 2017.
18. Tabar L, Vitak B, Chen TH-H, et al: Swedish two-county trial: Impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658-663, 2011.
19. Olsen AH, Njor SH, Vejborg I, et al: Breast cancer mortality in Copenhagen after introduction of mammography screening: Cohort study. BMJ 330: 220, 2005.
20. Baker SG, Kramer BS, Prorok PC: Statistical issues in randomized trials of cancer screening. BMC Med Res Methodol 2:11, 2002.
21. Oeffinger KC, Fontham ETH, Etzioni R, et al: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314:1599-1614, 2015.
22. Garćia-Albéniz X, Hsu J, Hernán MA: The value of explicitly emulating a target trial when using real world evidence: An application to colorectal cancer screening. Eur J Epidemiol 32: 495-500, 2017.
23. Jacobsen KK, von Euler Chelpin M, Vejborg I, et al: Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark. J Med Screen 24:20-26, 2017.
24. Blichert-Toft M, Christiansen P, Mouridsen HT: Danish Breast Cancer Cooperative Group- DBCG: History, organization, and status of scientific achievements at 30-year anniversary. Acta Oncol 47: 497-505, 2008.
25. Andreasen AH, Andersen KW, Madsen M, et al: Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer 70:133-137, 1994.